Member Info for bewise

V good appointment...

Big money to be made in sucessful copd and asthma treatments, just looking at Vectura, 554 could be one day up there with the big boys....:)

Wrong board though Atym is one to watch...

Big money to be made in sucessful copd and asthma treatments, just looking at Vectura, 554 could be one day up there with the big boys....:)

Good article from June 2016 re vrp and road ahead :) if you care to google.

Piripiri, where is this reported? 554 does seem to be something special especially with its very low side effect profile, interesting and hopefully profitable times ahead!

The new data from the last tests will be officially presented at this conference so again our profile will be enhanced within this sector....all positive stuff for us pi's

Good stuff :)

The impessive list of II are here to make a huge profit on their investment not a loss guys, need to keep this in mind guys imo :) including the chairman whose invested i think over 100k of his own money :)

http://www.veronapharma.com/joomla/images/VRP_AGM_27_June_2016.pdf

SP dropping on small volume, the ebbs and flows of aim I'm afraid....imo You would imagine JAK New York conference would be in line with vrp pursuing a nasdaq listing.....

New Hardman update out, a very good and encouraging read :)

http://www.veronapharma.com/joomla/ JAK presenting in New York 16/17 August: ta mol for highlighting

Is years off from the market if it succeeds through the phases, Asthma and copd are two different conditions....rpl554 is as effective for the treatment of asthma as the one currently on the market, the difference being 554 has considerably less side effect profile....Today and past directors buys and the volume of large trades over the past week are good indicators on where this is going imo along with the high quality of II backers...

A possible interesting week ahead!!

I think we are going to see much more of this imo, vrp is one to watch!

Will we see more big trades this week? I would imagine so as we are fully funded.....let's see what happens!

New treatment will take years to come to market if it all though I hope so as it would be of great benefit to sufferers.....could be an interesting development for 554 as a combo with this in the future...:)

Strange few days though good to see big buy trades....

The buyer is confident here, I would assume they must reckon on a good return on their investment :)